Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study
Diabetes, Obesity and Metabolism · 2026-08 · 28 (8) · 6755-6766
DOI: 10.1111/dom.70869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 11.05.2026. Verfasst von Vaios Koutroukas und 18 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, University of Leicester, College of Life Sciences, Leicester, UK. Hauptthemen laut MEDLINE: Hypoglycemia, Insulin, Diabetes Mellitus, Type 1, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative 2 Joint Undertaking (JU), European Union's Horizon 2020 Research and Innovation Programme and European Federation of Pharmaceutical Industries and Associations and T1D Exchange, Juvenile Diabetes Research Foundation, International Diabetes Federation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Gold and Clarke questionnaires are used to identify impaired awareness of hypoglycaemia (IAH) and severe hypoglycaemic event (SHE) risk in people with diabetes (pwD). We explored their overlap, including Clarke's Hypoglycaemia Awareness Status (Clarke‐HAS) subfactor, and subsection differences in SHE incidence (Gold, Clarke, overlap). Materials and Methods This post hoc analysis of the Hypo‐METRICS study recruited pwD on insulin (type 1: T1D; type 2: T2D) with ≥ 1 hypoglycaemic event in the previous 3 months. IAH was defined as Gold ≥ 4, Clarke ≥ 4, Clarke‐HAS ≥ 2.
Results
Gold and Clarke were completed by 232 pwT1D and 285 pwT2D (age: 47 vs. 62 years, p < 0.001; HbA1c: 56 mmol/mol (7.3%) vs. 57 mmol/mol (7.4%), p = 0.03). IAH prevalence in T1D vs. T2D was 21% vs. 26% ( p = 0.1), 14% vs. 18% ( p = 0.2), and 41% vs. 48% ( p = 0.2) according to Gold, Clarke and Clarke‐HAS. The overlap between Gold ≥ 4, Clarke ≥ 4 was 40% (T1D: 45%; T2D: 37%); between Gold ≥ 4, Clarke‐HAS ≥ 2 it was 45% (T1D: 43%; T2D: 47%). The overlap between Gold ≥ 4, Clarke ≥ 4 was 41% vs. 39% in CGM vs. non‐CGM users (T1D: 50% vs. 35%; T2D: 32% vs. 40%); between Gold ≥ 4, Clarke‐HAS ≥ 2 it was 39% vs. 53% (T1D: 38% vs. 54%; T2D: 40% vs. 53%). In the IAH sample, SHE rate was lower in people found with IAH by Gold vs. Clarke, 9% vs. 53%, and in those assessed by Gold‐Clarke overlap vs. Clarke, 20% vs. 53% (all p < 0.001).
Conclusions
Gold and Clarke show moderate consistency (37%–54%) in identifying IAH in insulin‐treated diabetes, with/without CGM use, each associated with different SHE rates, indicating the two questionnaires measure different, independent aspects of IAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Research Centre, University of Leicester, College of Life Sciences, Leicester, UK.
- Leicester Diabetes Centre, Leicester General Hospital, Leicester, UK.
- St. Vincent's University Hospital, Dublin, University College Dublin, Dublin, Ireland.
- School of Psychology, Deakin University, Melbourne, Australia.
- The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria, Australia.
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
ORCID-Profile: Vaios Koutroukas, Simon Heller, Julia K Mader, Ulrik Pedersen-Bjergaard, Eric Renard, Mark L Evans, Rory J McCrimmon
Förderung
- Innovative Medicines Initiative 2 Joint Undertaking (JU)
- European Union's Horizon 2020 Research and Innovation Programme and European Federation of Pharmaceutical Industries and Associations and T1D Exchange
- Juvenile Diabetes Research Foundation, International Diabetes Federation
- The Leona M. and Harry B. Helmsley Charitable Trust
- Breakthrough T1D
- Leona M. and Harry B. Helmsley Charitable Trust
Zitieren
APA
Koutroukas, V., Thomas, J., Martine-Edith, G., Tziannou, A., Divilly, P., Søholm, U., Meek, C. L., Heller, S., Mader, J. K., Pedersen-Bjergaard, U., de Galan, B. E., Renard, E., Evans, M. L., McCrimmon, R. J., Speight, J., Pouwer, F., Amiel, S. A., Choudhary, P., & Hypo‐RESOLVE consortium (2026). Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study. Diabetes, Obesity and Metabolism, 28(8), 6755-6766. https://doi.org/10.1111/dom.70869
Vancouver
Koutroukas V, Thomas J, Martine-Edith G, Tziannou A, Divilly P, Søholm U, et al. Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study. Diabetes, Obesity and Metabolism. 2026;28(8):6755-6766. doi:10.1111/dom.70869
BibTeX
@article{Koutroukas2026,
author = {Koutroukas, Vaios and Thomas, Jonah and Martine-Edith, Gilberte and Tziannou, Aikaterina and Divilly, Patrick and Søholm, Uffe and Meek, Claire L and Heller, Simon and Mader, Julia K and Pedersen-Bjergaard, Ulrik and de Galan, Bastiaan E and Renard, Eric and Evans, Mark L and McCrimmon, Rory J and Speight, Jane and Pouwer, Frans and Amiel, Stephanie A and Choudhary, Pratik and Hypo‐RESOLVE consortium, Hypo‐RESOLVE consortium},
title = {Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {8},
pages = {6755--6766},
doi = {10.1111/dom.70869}
}
EUVIMED